Professor and Head of the Department of Urological Surgery Christopher Evans has received an honorary membership in the European Association of Urology (EAU), which promotes the highest standards of urological care throughout Europe.
Evans is the ninth American to receive this award, reflecting his contribution to the development of urology in Europe. These include the training of several European clinical and research staff, as well as lectures and demonstration operations at European universities.
Over the past five years, he has performed demonstration surgeries at the University of Hamburg and the University Hospital of Tübingen in Germany. He also performed similar demonstration surgeries at the University of San Raffaele in Milan, Italy, and at the Fundacio Puivgert Hospital in Barcelona, Spain.
“Over the past 25 years, I have made many friends and many collaborations across Europe and I am very grateful for this recognition and all the positive interactions,” Evans said.
The opening ceremony of the 38th Annual EAU Congress in Milan this month provided an opportunity for the European Association of Urology to honor this year’s distinguished laureates. At this year’s meeting, Evans also delivered a course on prostate cancer for the European School of Urology and also gave several lectures.
This year the EAC is celebrating its 50th anniversary.th anniversary of the year. It is the leading body in Europe for urological practice, research and education. More than 18,000 healthcare professionals have joined its ranks and contributed to raising the level of urological care in Europe and beyond.
As President of the U.S. Society of Urological Oncology from 2017 to 2019, Evans developed the Scholars Exchange Program between the two societies and also co-edited two textbooks now used in European medical schools.
UC Davis Comprehensive Cancer Center
The UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and hinterland of Northern California, a region of over 6 million people. Its professionals provide compassionate, comprehensive care to more than 100,000 adults and children each year and have access to more than 200 active clinical trials at any given time. Its innovative research program involves more than 240 UC Davis scientists working together to discover new tools for cancer diagnosis and treatment. Patients have access to advanced medical care, including immunotherapy and other targeted therapies. Its Office of Public Affairs and Community Engagement eliminates disparities in cancer outcomes across populations, and the Cancer Center provides comprehensive training and workforce development programs for the next generation of physicians and scientists. For more information, visit Cancer.ucdavis.edu.